Marshall Wace LLP Cuts Stake in The Chemours Company (NYSE:CC)

Marshall Wace LLP trimmed its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 0.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,085,335 shares of the specialty chemicals company's stock after selling 31,619 shares during the period. Marshall Wace LLP owned approximately 4.74% of Chemours worth $119,742,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. HighTower Advisors LLC increased its holdings in shares of Chemours by 10.1% during the third quarter. HighTower Advisors LLC now owns 15,020 shares of the specialty chemicals company's stock valued at $300,000 after acquiring an additional 1,384 shares in the last quarter. Barclays PLC increased its stake in Chemours by 28.4% during the 3rd quarter. Barclays PLC now owns 107,549 shares of the specialty chemicals company's stock valued at $2,185,000 after purchasing an additional 23,766 shares in the last quarter. Geode Capital Management LLC raised its holdings in Chemours by 1.2% during the third quarter. Geode Capital Management LLC now owns 2,491,748 shares of the specialty chemicals company's stock worth $50,646,000 after buying an additional 28,803 shares during the last quarter. M&T Bank Corp lifted its stake in shares of Chemours by 4.1% in the third quarter. M&T Bank Corp now owns 510,343 shares of the specialty chemicals company's stock valued at $10,370,000 after buying an additional 20,122 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Chemours by 99.7% during the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 765 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on CC shares. The Goldman Sachs Group lowered their target price on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a report on Tuesday, January 7th. Truist Financial reduced their target price on Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a report on Monday, April 14th. Mizuho set a $15.00 price objective on Chemours in a research report on Tuesday, April 15th. BMO Capital Markets lowered their target price on Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 19th. Finally, Barclays decreased their price objective on shares of Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a report on Tuesday, April 1st. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Chemours has a consensus rating of "Moderate Buy" and a consensus target price of $21.56.

Chemours Stock Up 6.0 %

Shares of NYSE CC traded up $0.68 during mid-day trading on Tuesday, hitting $12.00. 734,807 shares of the stock traded hands, compared to its average volume of 1,835,754. The stock has a fifty day moving average price of $13.71 and a 200-day moving average price of $17.24. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The company has a market cap of $1.79 billion, a price-to-earnings ratio of 21.03 and a beta of 1.84. The Chemours Company has a 52 week low of $9.33 and a 52 week high of $29.21.

Chemours (NYSE:CC - Get Free Report) last released its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. Research analysts anticipate that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were given a $0.25 dividend. The ex-dividend date was Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.33%. Chemours's dividend payout ratio is currently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.